Company Description

The Veil Platform was developed by rearranging the structure of PEG-based polymers into small, discrete units that are significantly less immunogenic. This means that their polymers confer PK extension, stability, and shielding without the immune response. This structural rearrangement adopts a bottlebrush structure, creating a high-density polymer shield near the surface of the protein, where it’s needed most.